Clinical trial / 2017
Encapsulated fruit and vegetable juice concentrate reduced total cholesterol, LDL cholesterol, and plasma TNFα, and increased lean mass in overweight/obese adults.
A double-blind, parallel, randomized placebo-controlled trial examined the effects of eight weeks of daily supplementation with six capsules of fruit and vegetable juice concentrate or placebo in 56 overweight and obese adults aged ≥40 years. Following consumption of the juice concentrate, total cholesterol, LDL cholesterol, and plasma TNFα decreased and total lean mass increased, with no change in the placebo group. In participants with high baseline systemic inflammation (serum CRP ≥3.0 mg/mL, n = 16), these effects were greater, though plasma CRP remained unchanged. The concentrate also altered the expression of genes involved in lipogenesis, NF-κB, and AMPK signalling pathways, such as PMVK, ZFAND5, and CAB39.
- Study type
- Double-blind, parallel, randomized placebo-controlled trial
- Who was studied
- 56 adults aged ≥40 years with a BMI ≥28 kg/m²
- What was measured
- Peripheral blood gene expression, plasma TNFα, body composition, and lipid profiles
THE PAPER
Effects of an Encapsulated Fruit and Vegetable Juice Concentrate on Obesity-Induced Systemic Inflammation: A Randomised Controlled Trial.
Williams EJ, Baines KJ, Berthon BS, Wood LG. Nutrients, 2017.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.